fda glp-1 compounding restriction

FDA moves to restrict compounded versions of popular GLP-1 weight loss drugs — Photo by Maksim Goncharenok on Pexels

Experts Agree Prescription Weight Loss Is Broken?

Prescription weight-loss therapy is currently broken because the FDA ban on compounded GLP-1 drugs has driven up costs and limited access for seniors. The loss of low-cost bulk options forces retirees to choose between pricey brand kits or forgoing treatment. Medical Disclaimer: This article is for informational purposes only and